Related by context. All words. (Click for frequent words.) 74 cervical intraepithelial neoplasia 72 external genital lesions 70 dysplastic lesions 70 grade cervical intraepithelial 70 cervical lesions 70 invasive cervical cancer 70 vaginal lesions 69 neoplasias 69 CIN2 + 68 cervical dysplasia 68 precancerous cervical 68 chlamydial infection 68 precursor lesions 68 basal cell carcinoma BCC 68 nonmelanoma skin cancers 67 endometrial hyperplasia 67 CIN3 67 CMV infection 67 Human papillomavirus HPV 67 premalignant lesion 67 anal cancers 67 venous blood clots 67 ano genital warts 67 cervical vaginal 67 vaginal cancers 66 genital herpes infections 66 curable cancers 66 acute GvHD 66 cervical carcinoma 66 Candida infection 66 CIN2 66 quadrivalent vaccine 66 fallopian tube carcinoma 66 vaginal atrophy 66 grade cervical dysplasia 66 ductal breast cancer 66 cervical vulvar 66 GISTs 66 epithelial tumors 66 endometrial carcinoma 65 abnormal Pap tests 65 abnormal cytology 65 abnormal Pap smear 65 situ CIS 65 peritoneal cancer 65 type 1diabetes 65 Acute Myeloid Leukaemia AML 65 bladder cancers 65 skeletal metastases 65 Human Papilloma Virus HPV 65 testicular tumors 65 Trichomonas vaginalis 65 advanced adenoma 65 Human Papilloma Virus 65 precancers 65 FluCAM arm 65 Adjuvant chemotherapy 65 Epstein Barr virus EBV 65 orchitis 64 cervical cancer precancerous 64 nonproliferative 64 pre cancerous polyps 64 amenorrhoea 64 invasive carcinoma 64 recurrent metastatic 64 abnormal pap smears 64 epithelial ovarian cancer 64 recurrent glioblastoma multiforme 64 basal cell cancers 64 Benign prostatic hyperplasia BPH 64 cutaneous squamous cell carcinoma 64 intraepithelial neoplasia 64 HER2 overexpression 64 Endometrial cancer 64 systemic scleroderma 64 histologic subtype 64 seminoma 64 hemorrhagic cystitis 64 invasive candidiasis 64 lichen planus 64 colorectal adenoma 64 urethritis 64 HPV-#/# 64 Human papillomavirus 64 vulvar intraepithelial neoplasia 64 posterior uveitis 64 chlamydia infection 64 ASCUS 64 ductal cancer 64 renal flares 64 benign proliferative breast 63 advanced adenomas 63 squamous cell cancers 63 candidemia 63 epithelial ovarian 63 HGPIN 63 pre cancerous 63 complete cytogenetic response 63 myelodysplastic myeloproliferative diseases 63 genital lesions 63 ADPKD 63 proctitis 63 vulvar cancers 63 Testicular cancer 63 Human Papillomavirus 63 leiomyomas 63 gastrointestinal stromal tumors GIST 63 Heavy menstrual bleeding 63 varicella infection 63 HNSCC 63 breast abscesses 63 oncogenic HPV types 63 MGUS 63 HPV infections 63 Genital herpes 63 Chlamydia trachomatis infection 63 HPV subtypes 63 hepatitis C genotype 63 PCNSL 63 superficial bladder cancer 63 invasive aspergillosis 63 abnormal Pap smears 63 cytoreduction 63 metastatic gastric 63 Chlamydia infection 63 urothelial carcinoma 63 herpes zoster shingles 63 post thrombotic syndrome 63 metastatic malignant melanoma 62 shingles herpes zoster 62 VUR 62 precancerous condition 62 prostate cancer CaP 62 pre cancerous lesions 62 adenomatous polyps 62 Human Papillomavirus HPV 62 Hepatocellular Carcinoma HCC 62 relapsing remitting MS RRMS 62 gastric adenocarcinoma 62 hypercalcemia 62 prostate adenocarcinoma 62 Candida infections 62 leukemia AML 62 renal cell carcinomas 62 hematologic toxicity 62 recurrent bladder 62 invasive fungal infections 62 colorectal cancer CRC 62 bacterial vaginosis BV 62 vesicoureteral reflux 62 penile cancers 62 abnormal Pap 62 neuroendocrine cancers 62 antimicrobial prophylaxis 62 MALT lymphoma 62 chronic GVHD 62 S. aureus isolates 62 cancerous cervical lesions 62 ertapenem 62 metastatic bladder 62 leukemia ALL 62 radioiodine therapy 62 total thyroidectomy 62 cervical cancer genital warts 62 relapsed MM 62 LTBI 62 Chronic lymphocytic leukemia CLL 62 EXJADE 62 testicular cancers 62 aromatase inhibitors AIs 62 anal HPV 62 malignant neoplasms 62 cytomegalovirus infection 62 proliferative diabetic retinopathy 62 metastatic lung cancer 62 Adenomas 62 alemtuzumab treated 62 rotavirus diarrhea 62 parathyroid carcinoma 62 RSV infections 62 abnormal Pap test 62 Severe Primary IGFD 62 carcinoid tumors 62 BCG vaccinated 62 malignant neoplasm 62 hepatorenal syndrome 62 Chlamydia infections 62 superficial basal cell carcinoma 62 Glioblastoma Multiforme 62 Hib disease 62 anterior uveitis 62 GnRH agonists 62 Human papilloma virus 62 histological subtype 62 CTAP# Capsules 62 CIN3 + 62 testicular germ cell 62 non metastatic osteosarcoma 62 HBeAg 62 Hurthle cell 62 cholangiocarcinoma 62 chronic prostatitis 62 squamous cell carcinoma SCC 62 Mitomycin C 62 hepatocellular cancer 62 Malignant Melanoma 62 metastatic GIST 62 differentiated thyroid 62 CMV disease 62 squamous intraepithelial lesions 62 advanced neoplasia 62 endometrial cancers 62 Anaplastic 62 heavy menstrual bleeding 62 AA Amyloidosis 62 neuroendocrine carcinoma 62 gonococcal infection 62 human papillomavirus HPV 62 pulmonary metastases 62 nonmetastatic 62 primary hyperparathyroidism 61 hypereosinophilic syndrome 61 finasteride Proscar 61 thromboembolic 61 Bacterial vaginosis 61 resistant hormone refractory 61 haematologic 61 VivaGel TM 61 HPV# 61 mesotheliomas 61 herpes zoster vaccine 61 serotype #A 61 pemphigus vulgaris 61 invasive meningococcal disease 61 cranial radiation 61 malignant pleural mesothelioma 61 papillary carcinoma 61 AVODART 61 Extensively drug 61 renal scarring 61 corticosteroid therapy 61 chorioamnionitis 61 pelvic malignancies 61 oncogenic HPV 61 urothelial bladder cancer 61 intestinal metaplasia 61 androgenetic alopecia 61 Chronic Myelogenous Leukemia CML 61 lobular carcinoma 61 recurrent VTE 61 heparin induced thrombocytopenia 61 colorectal neoplasms 61 atrophic gastritis 61 Acute myeloid leukemia 61 Recurrences 61 chronic HBV 61 trichomonas 61 pneumococcal pneumonia 61 androgen deprivation 61 severe rotavirus gastroenteritis 61 S. aureus infection 61 LNG IUS 61 osteosarcomas 61 dysplastic lesions caused 61 gynecologic malignancy 61 ALT flares 61 curative resection 61 Enlarged prostate 61 ovarian tumors 61 grade squamous intraepithelial 61 atypical ductal hyperplasia 61 bacteriuria 61 Tindamax R 61 nonvaccine 61 metastatic neuroendocrine tumors 61 varices 61 osteosarcoma rare 61 Basal cell 61 Staphylococcus aureus infections 61 Hib meningitis 61 non hematological toxicities 61 invasive fungal infection 61 preventing genital warts 61 palliative radiotherapy 61 candidiasis 61 quadrivalent HPV vaccine 61 bacterial vaginosis 61 erythema nodosum 61 MCyR 61 symptomatic fibroids 61 upper gastrointestinal bleeding 61 Bezielle 61 Cervista HPV HR 61 BRCA2 mutation carriers 61 benign prostatic hypertrophy 61 Cholangiocarcinoma 61 benign nodules 61 HCV infections 61 atypical hyperplasia 61 abnormal uterine bleeding 61 thromboembolic disease 61 Candidiasis 61 prostate cancer PCa 61 CMV infections 61 hemorrhagic complications 61 underwent resection 61 Ductal carcinoma 61 hyperplasia BPH 61 coinfection 61 nonvertebral fracture 61 osteoporotic vertebral compression fractures 61 acute myelogenous leukemia AML 61 invasive ductal 61 vaccinees 61 histologically confirmed 61 #.#ng/ml 61 overactive bladder syndrome 61 genital HPV infection 61 Bronchiectasis 61 Uterine fibroids 61 Genital warts 61 Hepatitis C virus HCV 61 ovarian cancers 61 anemia hemoglobin 61 IV bisphosphonates 61 bacterium Neisseria meningitidis 61 bladder carcinoma 61 prolonged QT interval 61 anogenital warts 61 castrate resistant prostate cancer 61 thromboembolic events 61 vaginal yeast infections 61 chlamydial infections 61 neoadjuvant therapy 61 postoperative infection 61 DVT PE 61 Benign Prostatic Hyperplasia BPH 61 low expressors 61 lymphopenia 61 metastatic lesions 61 vWD 61 Ribavirin causes 61 polyp recurrence 60 metastatic colorectal 60 LHRH receptor positive 60 basal cell carcinomas 60 HBeAg positive patients 60 choriocarcinoma 60 trans retinoic acid ATRA 60 HER2 expression 60 CP CPPS 60 breast carcinomas 60 N. gonorrhoeae 60 polycystic ovary syndrome PCOS 60 clinically detectable 60 KRAS mutations occur 60 pancreatic NET 60 mycophenolate mofetil 60 operable breast cancer 60 serogroup B 60 CERVARIX 60 cervical abnormalities 60 delayed CINV 60 bone metastasis 60 cervical precancer 60 GARDASIL ® 60 intravenous bisphosphonates 60 Pseudomonas aeruginosa infections 60 symptomatic aortic stenosis 60 HER2 positive cancers 60 Ophena TM 60 heterozygous FH 60 beta estradiol 60 hyperphenylalaninemia HPA due 60 antigen PSA 60 squamous cell lung cancer 60 Basal cell carcinoma 60 nonmelanoma skin cancer 60 smoldering myeloma 60 minimally symptomatic metastatic castrate 60 serous ovarian cancer 60 chronic idiopathic thrombocytopenic purpura 60 post surgical adhesions 60 FASLODEX 60 protease inhibitors PIs 60 benign breast 60 lymph node biopsies 60 nonsmall cell lung cancer 60 androgen suppression therapy 60 artery embolization 60 neoplasia 60 cutaneous melanoma 60 lupus erythematosus 60 Chronic hepatitis B 60 varicella zoster virus VZV 60 SJIA 60 prostate TURP 60 severe hypersensitivity reactions 60 ovarian carcinoma 60 biochemical relapse 60 acute promyelocytic leukemia 60 pharyngeal cancer 60 oral squamous cell 60 Papillary 60 gonorrhea infections 60 recurrent atrial fibrillation 60 proliferative retinopathy 60 gastrointestinal stromal tumor GIST 60 cytoreductive surgery 60 mucocutaneous reactions 60 penicillin allergy 60 clinically localized prostate 60 Gastric cancer 60 gastrointestinal toxicities 60 pericardial effusion 60 nodal metastasis 60 Recombinant interferon alpha 60 histopathologic examination 60 Pap smear screening 60 invasive lobular carcinoma 60 precancerous tumors 60 P. falciparum malaria 60 resectable 60 S. aureus infections 60 Androgen deprivation therapy 60 Toxicities 60 AGILECT R 60 IgA antibodies 60 breast carcinoma 60 Squamous 60 latent tuberculosis infection 60 myelodysplastic syndrome MDS 60 NAbs 60 transfusion syndrome 60 recurrent genital herpes 60 undergoing radical prostatectomy 60 pituitary adenomas 60 vertebral fracture 60 Vaccine Recombinant 60 pneumococci 60 HBeAg negative 60 azoospermia 60 juvenile idiopathic arthritis 60 HBeAg seroconversion 60 imatinib resistance 60 grade glioma 60 invasive prenatal 60 polycystic ovarian syndrome PCOS 60 systemic fungal infections 60 pathologic fractures 60 latent tuberculosis TB 60 BRCA deficient 60 OAB symptoms 60 Twinrix 60 keloid scarring 60 spontaneous preterm birth 60 PPCM 60 hormone receptor negative 60 intravascular hemolysis 60 caspofungin 60 subependymal giant cell 60 HeFH 60 malignant ascites 60 malignant melanomas 60 anemia neutropenia 60 non squamous NSCLC 60 neutropaenia 60 herpesviruses 60 glioblastoma brain tumor 60 endocrine therapies 60 medullary thyroid cancer 60 chlamydial 60 Chronic lymphocytic leukemia 60 recurrent UTI 60 cisplatin chemotherapy 60 MAGE A3 ASCI 60 chronic eosinophilic leukemia 60 Aortic stenosis 60 thymoma 60 ovarian malignancy 60 tuberculin skin testing 60 hypercholesterolaemia 60 vulvar vaginal 60 fetal malformations 60 CMV reactivation 60 BRSV 60 virus RSV 60 combination antiretroviral therapy 60 cervical cancers 60 grade dysplasia 60 node metastases 60 CMV retinitis 60 basal cell nevus syndrome 60 relapsed ovarian cancer 60 HPV Types 60 genital wart 60 ductal carcinomas 60 hormone refractory 60 quinolone 60 pelvic inflammatory disease 60 antibody MAb 60 CYT# potent vascular disrupting 60 preventing precancerous lesions 60 colorectal polyp 60 colorectal carcinoma 60 embryonal rhabdomyosarcoma 60 pneumococcal infections 60 mRCC 60 Chronic Prostatitis 60 simplex virus 60 cervical cancer 60 refractory gout 60 Cervista HPV 60 tumors GIST 60 Venous thromboembolism 60 recurrent ovarian 59 prostate cancer CRPC 59 NNRTI resistance 59 DEFLUX 59 pelvic lymphadenectomy 59 mycosis fungoides 59 immunosuppressed patients 59 peripheral sensory neuropathy 59 AGHD 59 BRCA mutation 59 specific antigen PSA 59 Relapsing remitting MS 59 bacterial prostatitis 59 hepatitis B infection 59 MenB 59 pre malignant lesions 59 intraductal 59 transaminase elevations 59 cancerous enlargement 59 fibroadenomas 59 vaccine serotypes 59 Clostridium difficile infections 59 HBV infections 59 recurrent DVT 59 NMIBC 59 lobular cancer 59 hepatocellular carcinoma HCC 59 undergone radical prostatectomy 59 VFEND 59 Surgical resection 59 RSV infection 59 inconclusive Pap 59 PCa 59 undergoing hysterectomy 59 Brain metastases 59 EUS FNA 59 laparoscopically assisted 59 micafungin 59 adverse reactions incidence 59 menstrual migraines 59 metastatic renal cell 59 invasive ductal breast cancer 59 nephrotoxicity 59 refractory ovarian cancer 59 forodesine 59 Opportunistic infections 59 alveolar rhabdomyosarcoma 59 overt hepatic encephalopathy HE 59 gonococcal 59 peritoneal carcinomatosis 59 pathologic fracture 59 serum phosphate 59 GIST tumors 59 pancreatic lung 59 quadrivalent 59 LHRH analogues 59 anal lesions 59 squamous cell 59 oropharyngeal candidiasis OPC 59 abnormal pap tests 59 obstructive coronary 59 pCR 59 nonvaccine serotypes 59 Follicular Lymphoma 59 endometriosis ovarian cysts 59 renal carcinoma 59 Vidaza azacitidine 59 nucleoside analogues 59 IgA deficiency 59 stratifying patients 59 sensory neuropathy 59 XDR tuberculosis 59 neurofibromas 59 cytogenetic responses 59 squamous cell cancer 59 carotid stenosis 59 Fludara ® 59 Acute lymphoblastic leukemia 59 lymphocytic leukemia 59 lupus nephritis 59 chronic HBV infection 59 Glioblastoma multiforme GBM 59 pediatric acute lymphoblastic 59 Androgenetic Alopecia 59 uterine tumors 59 grade gliomas 59 gastrointestinal stromal tumor 59 CCyR 59 Postoperative complications 59 indolent lymphoma 59 malignant ovarian 59 HPV types 59 aspartate aminotransferase AST 59 TNF antagonist 59 ovarian hyperstimulation syndrome OHSS 59 metastatic adenocarcinoma 59 solar keratoses 59 adenoma 59 Urinary tract infections 59 Bacterial Vaginosis 59 smoldering multiple myeloma 59 aromatase inhibitor therapy 59 leiomyosarcoma 59 postoperative atrial fibrillation 59 gastrointestinal stromal tumors 59 HPV genotypes 59 chronic HCV 59 Gliomas 59 overactive bladder OAB 59 precancerous lesions 59 pT2 59 AAT deficiency 59 Onychomycosis 59 vasogenic edema 59 pneumocystis 59 Paraplatin ® 59 uterine fibroid tumors 59 S. aureus colonization 59 colorectal liver metastases 59 bladder tumors 59 Glioblastoma Multiforme GBM 59 breast uterine 59 B Cell Lymphoma 59 cytotoxic therapy 59 juvenile idiopathic arthritis JIA 59 cervical precancerous lesions 59 KRAS status 59 clinically asymptomatic 59 autoantibody positive 59 serum prostate 59 inflammatory acne 59 Legg Calvé Perthes disease 59 bowel cancers 59 genital human papillomavirus 59 intraoperative complications 59 intravesical therapy 59 Soft Tissue Sarcoma 59 acne vulgaris 59 Dacogen decitabine 59 needle aspiration 59 metastatic kidney 59 primary immunodeficiency PI 59 urothelial cancer 59 acute leukemias 59 pyelonephritis 59 allograft rejection 59 ribavirin therapy 59 secondary amenorrhea 59 CIMZIA ™ 59 Hodgkin lymphoma HL 59 Lung transplantation 59 thrombotic complications 59 posaconazole 59 vulvar 59 BRCA2 gene mutation 59 painful menstruation 59 gastric carcinoma 59 BCG refractory carcinoma 59 Human Virus HPV 59 HBV infection 59 recurrent infections 59 Uterine cancer 59 serum testosterone 59 PASI scores 59 gestational hypertension 59 intra abdominal infections 59 dasatinib Sprycel 59 intestinal polyps 59 HPV 59 non hodgkin lymphoma 59 T1DM 59 postexposure prophylaxis 59 HNPCC 59 PHPT 59 histologically proven 59 Chlamydia trachomatis 59 contrast induced nephropathy 59 diagnosing coronary artery 59 uterine fibroid 59 infectious mononucleosis 59 locoregional recurrence 59 axillary lymph nodes 59 chronic hepatitis 59 Oesophageal cancer 59 hypertrophic scars 59 cerebral vasospasm 59 diagnostic modality 59 acute GVHD 59 mycophenolate mofetil MMF 59 cystic fibrosis chronic pancreatitis 59 ALCL 59 Candida species 59 anaplastic astrocytoma 59 Malignant melanoma 59 opioid induced constipation OIC 59 Adhibit 59 often detect precancerous 59 refractory prostate cancer 59 renal biopsy 59 hematologic adverse 59 antiandrogens 59 myoma 59 efalizumab 59 neoplasm 59 Arranon 59 dysglycemia 59 premalignant 59 HPV infection 59 Chronic pancreatitis 59 colorectal bowel 59 C. difficile colitis 59 deletion 5q 59 postoperative pulmonary 59 evaluable subjects 59 overactive bladder symptoms 59 neoplasia PIN 59 nonmalignant 59 recurrent miscarriage 59 Infusion Reactions Severe 59 perioperative morbidity 59 penile anal 59 Lupus nephritis 59 elevated ALT 59 tipranavir ritonavir 58 rindopepimut 58 minimally symptomatic 58 Osteoarthritis OA 58 obstructive coronary artery 58 dual endothelin receptor antagonist 58 hypophosphatemia 58 anthracycline therapy 58 anaplastic 58 Actinic Keratosis 58 paralytic polio 58 C. trachomatis 58 hormone deprivation 58 thromboembolic complications 58 Aspergillus infections 58 B7 H3 58 Leber congenital amaurosis LCA 58 astrocytomas 58 renal toxicity 58 Hepatocellular carcinoma HCC 58 membranous nephropathy 58 metastatic renal cell carcinoma 58 Acute Myeloid Leukaemia 58 cancerdefine 58 LYSTEDA 58 prostate carcinoma 58 urethral stricture 58 prostate walnut 58 rheumatologic 58 cryptococcal meningitis 58 situ LCIS 58 benign polyps 58 Vitamin B# deficiency 58 varicoceles 58 PSA nadir 58 familial adenomatous polyposis 58 POAG 58 hypersensitivity reaction 58 HAV infection 58 severe neutropenia 58 psoriatic arthritis PsA 58 b Hib 58 chronic hepatitis cirrhosis 58 macrolide antibiotic 58 ocular toxicity 58 systemic lupus erythematosus SLE 58 invasive Hib 58 leucopenia 58 BRCA mutation carriers 58 immune thrombocytopenic purpura ITP 58 suppressive therapy 58 methicillin susceptible Staphylococcus aureus 58 glycated hemoglobin levels 58 idiopathic PAH 58 rheumatic disease 58 alpha1 antitrypsin deficiency 58 Non Hodgkin 58 thyroid nodules 58 pre cancerous growths 58 P. vivax malaria 58 alkylating agents 58 ankylosing spondylitis AS 58 Colon polyps 58 castrate resistant 58 ventricular dysplasia 58 locoregional 58 Radical prostatectomy 58 metachronous 58 autoimmune thyroiditis 58 immunocompetent 58 sCJD 58 malignant lymphoma 58 ZOSTAVAX 58 abnormal pap smear 58 HbF 58 beta blocker therapy 58 Interferon beta 1b 58 cranial irradiation 58 VTEs 58 epiglottitis 58 untreated chlamydia 58 nonalcoholic steatohepatitis NASH 58 hepatitis C HCV 58 bullous 58 cirrhosis liver failure 58 hereditary breast cancer 58 Pemetrexed 58 monoclonal antibody conjugated 58 treat benign prostatic 58 recurrent NSCLC 58 fibroids endometriosis 58 taxane therapy 58 Benign breast 58 glucocorticoid induced osteoporosis 58 serum calcium levels 58 leukoencephalopathy 58 Acute Radiation Syndrome ARS 58 hematopoietic cancers 58 hematologic abnormalities 58 Thyroid cancer 58 chlamydia trachomatis 58 staphylococcal infections 58 malignant pleural mesothelioma MPM 58 intradermal injection 58 cervical neoplasia 58 androgenic alopecia 58 renal tumors 58 SNT-MC#/idebenone 58 LHRH antagonists 58 interferon beta therapy 58 Gorlin syndrome 58 oral FTY# 58 Dasatinib 58 anal incontinence 58 gynecological cancers 58 neurologic complications 58 knee osteoarthritis OA 58 retrograde ejaculation 58 Urinary tract infections UTIs 58 Hashimoto thyroiditis 58 lumbar spinal stenosis LSS 58 genotypic resistance 58 HIV HCV coinfected 58 immuno compromised patients 58 metastatic prostate 58 assessing T DM1 58 S. aureus bacteremia 58 dysmenorrhoea 58 BCG refractory 58 cervical intraepithelial neoplasia CIN 58 vulvar lesions 58 prostate cancers 58 neutropenic patients 58 bacteraemia 58 lung pancreatic 58 variceal hemorrhage 58 polyomavirus nephropathy 58 del 5q MDS 58 varicocele 58 tuberous sclerosis TS 58 Dr Zorbas 58 gonococcal infections 58 fallopian tube cancers 58 bronchopulmonary dysplasia 58 adenomatous 58 LVNC 58 curative therapy 58 oropharyngeal cancer 58 metastatic renal 58 malignancies 58 Glioblastoma multiforme 58 neutropenia dehydration dyspnea 58 LHRH agonists 58 GABHS 58 invasive lobular 58 Measles mumps 58 thromboses 58 Mitoxantrone 58 epididymitis 58 tyrosine kinase inhibitors TKIs 58 virologic failure 58 IV NSCLC 58 PSADT 58 gross hematuria 58 urolithiasis 58 liposomal amphotericin B 58 Oral contraceptives 58 cervix uteri 58 tumor recurrence 58 rotavirus gastroenteritis 58 hypothalamic amenorrhea 58 paragangliomas 58 Gleevec resistant 58 pneumococcal infection 58 malignant polyps 58 sonographic diagnosis 58 esophageal cancers 58 seroma formation 58 chronic HCV infection 58 repigmentation 58 non squamous 58 anal intraepithelial neoplasia 58 pneumococcal strains 58 mycobacterial infections 58 Skin rashes 58 herpes zoster virus 58 glucocorticoid therapy 58 herpes zoster 58 precancer 58 Neisseria gonorrhoeae 58 antibody titer 58 gastrointestinal malignancies 58 Menopausal hormone therapy 58 atopic eczema 58 genital ulcers 58 astrocytoma 58 abnormal mammogram 58 ximelagatran 58 gonorrhea chlamydia 58 primary ovarian insufficiency 58 tumor histology 58 Prostatitis 58 receptor tyrosine kinase inhibitor 58 vulvar cancer 58 basal cell skin 58 atrophic vaginitis 58 BARACLUDE ® 58 decompensated liver disease 58 VZV 58 bacterium Mycobacterium tuberculosis 58 bladder ovarian 58 chlamydia infections 58 severe oral mucositis 58 cSSSIs 58 ticlopidine 58 Immune reconstitution syndrome 58 familial hypercholesterolemia 58 PAP smears 58 Polycythemia vera 58 estrogen hormone therapy 58 diabetic gastroparesis 58 Wegener granulomatosis 58 malignant lesions 58 Crizotinib 58 esophageal candidiasis 58 tigecycline 58 Natalizumab 58 acute aortic dissection 58 reflux disease GERD 58 elevated triglyceride levels 58 nucleoside analogue 58 allogeneic HSCT 58 stage IIIB 58 thrombophilia 58 Renal impairment 58 carcinoid 58 acute lymphoid leukemia 58 TMP SMX 58 ruptured aneurysms 58 pegfilgrastim 58 urinary symptoms 58 pulmonary fungal infections 58 immunopathology 58 Ovarian cysts 58 enterovirus infection 58 PAOD 58 prostate cancer HRPC 58 moderately emetogenic 58 anthracycline taxane 58 MYCN amplification 58 â ‰ ¥ 58 infective endocarditis 58 STRIDE PD 58 situ DCIS 58 vaginal candidiasis 58 PPSV# 58 vaginal microbicides 58 venous thromboembolic events 58 chronic periodontitis 58 Plaque psoriasis 58 Colorectal cancers